Meeder Asset Management Inc Aclaris Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$12.27 - $18.49 $29,239 - $44,061	-2,383 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$13.38 - $18.8 $31,884 - $44,800	2,383 New	2,383 $43,000
Q2 2020 Aug 11, 2020	SELL	$1.04 - $1.73 $822 - $1,368	-791 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.75 - $2.18 $318 - $926	-425 Reduced 34.95%	791 $0
Q4 2019 Feb 13, 2020	SELL	$1.02 - $1.97 $3,446 - $6,656	-3,379 Reduced 73.54%	1,216 $2,000
Q3 2019 Oct 17, 2019	BUY	$0.79 - $2.47 $3,118 - $9,749	3,947 Added 609.1%	4,595 $5,000
Q2 2019 Aug 05, 2019	SELL	$2.13 - $7.06 $2,161 - $7,165	-1,015 Reduced 61.03%	648 $1,000
Q1 2019 Apr 16, 2019	BUY	$5.63 - $7.84 $2,719 - $3,786	483 Added 40.93%	1,663 $10,000
Q4 2018 Jan 17, 2019	BUY	$6.3 - $15.4 $7,434 - $18,172	1,180 New	1,180 $9,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $195M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.